Castleman Disease Trial, Recruiting (NCT03300830)

Castleman Disease Trial, Recruiting NCT03300830 Sponsor: National Cancer Institute (NCI) Condition: Castleman Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03300830 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Castleman Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have HIV or another condition that weakens the immune system, along with cancer
You have a type of cancer that is thought to be caused by a virus
You are HIV-negative but have a type of cancer that commonly occurs in people who have HIV
You have a cancer or condition linked to a specific virus called KSHV, such as Multicentric Castleman Disease
You have a cancer thought to be caused by a virus naturally found in the human body (confirm with trial site)
You have a condition called Idiopathic Castleman Disease (a rare disorder affecting the lymph nodes)
You are generally well enough to have a biopsy if needed (your doctor will assess this based on your overall health), or you are enrolling only to have already-collected tissue studied
You are willing to sign a consent form allowing your tumor samples and other tissues to be used for research
You are already taking part in other related research studies at the NIH

Who may not be able to join:

You are unable to give your own informed consent to take part in the study
You are currently pregnant, as there is no direct benefit identified for pregnant women in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert Yarchoan, M.D., National Cancer Institute (NCI)

Phone: (240) 760-6126

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03300830

Sponsor: National Cancer Institute (NCI)

Phase: Not Applicable

Status: Recruiting

Condition: Castleman Disease

Trial contact: (240) 760-6126

More information: https://clinicaltrials.gov/study/NCT03300830

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have HIV or another condition that weakens the immune system, along with cancer
You have a type of cancer that is thought to be caused by a virus
You are HIV-negative but have a type of cancer that commonly occurs in people who have HIV
You have a cancer or condition linked to a specific virus called KSHV, such as Multicentric Castleman Disease
You have a cancer thought to be caused by a virus naturally found in the human body (confirm with trial site)
You have a condition called Idiopathic Castleman Disease (a rare disorder affecting the lymph nodes)
You are generally well enough to have a biopsy if needed (your doctor will assess this based on your overall health), or you are enrolling only to have already-collected tissue studied
You are willing to sign a consent form allowing your tumor samples and other tissues to be used for research
You are already taking part in other related research studies at the NIH

Who may not be able to join:

You are unable to give your own informed consent to take part in the study
You are currently pregnant, as there is no direct benefit identified for pregnant women in this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute (NCI)

Registry

ClinicalTrials.gov

Start date

20 December 2017

Est. completion

7 June 2037

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Tissue collection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov